CRISPR‐mediated knockout of DRD1 in lung cancer cell lines significantly increases cell proliferation (Fig. 2A, Fig. S3A–C), as does shRNA‐mediated stable DRD1 knockdown (Fig. S4B,C). The gene discussed is DRD1; the disease is lung carcinoma.